HSPA13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.910600E-01
Normal-vs-Stage2
9.956600E-01
Normal-vs-Stage3
3.068000E-01
Normal-vs-Stage4
6.814400E-01
Stage1-vs-Stage2
4.260400E-01
Stage1-vs-Stage3
1.642580E-01
Stage1-vs-Stage4
8.905600E-01
Stage2-vs-Stage3
3.943000E-01
Stage2-vs-Stage4
6.223000E-01
Stage3-vs-Stage4
2.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.875800E-01
Normal-vs-AfricanAmerican
4.758200E-01
Normal-vs-Asian
4.611800E-01
Caucasian-vs-AfricanAmerican
3.152400E-01
Caucasian-vs-Asian
1.750560E-01
AfricanAmerican-vs-Asian
6.907900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.175000E-01
Normal-vs-Female
7.821600E-01
Male-vs-Female
5.841800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.645800E-01
Normal-vs-Age(41-60Yrs)
4.790400E-01
Normal-vs-Age(61-80Yrs)
9.548600E-01
Normal-vs-Age(81-100Yrs)
4.558600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.175400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.829600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.803010E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.963100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.377220E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.431400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.307400E-01
Normal-vs-Daily Drinker
4.087800E-01
Normal-vs-Weekly Drinker
9.552000E-01
Normal-vs-Occasional Drinker
5.634000E-01
Normal-vs-Social Drinker
5.972200E-01
Non Drinker-vs-Daily Drinker
5.735800E-01
Non Drinker-vs-Weekly Drinker
3.557000E-01
Non Drinker-vs-Occasional Drinker
5.395700E-02
Non Drinker-vs-Social Drinker
1.020400E-01
Daily Drinker-vs-Weekly Drinker
2.169000E-01
Daily Drinker-vs-Occasional Drinker
3.340000E-02
Daily Drinker-vs-Social Drinker
7.004500E-02
Weekly Drinker-vs-Occasional Drinker
1.944780E-01
Weekly Drinker-vs-Social Drinker
2.562400E-01
Occasional Drinker-vs-Social Drinker
9.830800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.836800E-01
Normal-vs-Grade 2
1.789040E-01
Normal-vs-Grade 3
2.547800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.538600E-01
Grade 1-vs-Grade 3
4.147400E-01
Grade 1-vs-Grade 4
2.836800E-01
Grade 2-vs-Grade 3
6.462000E-01
Grade 2-vs-Grade 4
1.789040E-01
Grade 3-vs-Grade 4
2.547800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.303400E-01
Normal-vs-NonDiabetic
9.164200E-01
Diabetic-vs-NonDiabetic
5.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.438200E-01
Normal-vs-NoPancreatitis
8.870000E-01
Pancreatitis-vs-NoPancreatitis
1.055670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.713200E-01
Normal-vs-N1
9.798400E-01
N0-vs-N1
2.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.428400E-01
Normal-vs-TP53-NonMutant
7.340400E-01
TP53-Mutant-vs-TP53-NonMutant
3.257800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
